Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Trends in Endocrinology and Metabolism: TEM|June 20, 2015
Nicolaus Copernicus and the rapid vascular responses to aldosteroneMatthias Barton, Matthias R MeyerThe Journal of Steroid Biochemistry and Molecular Biology|March 28, 2017
GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseasesMatthias R Meyer, Matthias BartonBritish Journal of Pharmacology|May 12, 2011
Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstrictionMatthias Barton, Oliver Baretella, Matthias R MeyerThe Canadian Journal of Cardiology|April 28, 2016
Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and TherapyMatthias Barton, Marc Husmann, Matthias R MeyerGender Medicine|May 28, 2008
Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosisMatthias R Meyer, Elvira Haas, Matthias BartonImmunology, Endocrine & Metabolic Agents in Medicinal Chemistry|July 8, 2014
GPER/GPR30 and Regulation of Vascular Tone and Blood PressureMatthias R Meyer, Eric R Prossnitz, Matthias BartonSteroids|September 14, 2019
Nox1 downregulators: A new class of therapeuticsMatthias Barton, Matthias R Meyer, Eric R ProssnitzVascular Pharmacology|July 12, 2011
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular functionMatthias R Meyer, Eric R Prossnitz, Matthias BartonLife Sciences|January 3, 2014
Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular agingMatthias R Meyer, Matthias Barton, Eric R ProssnitzJournal of Cardiovascular Pharmacology|April 26, 2013
Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilationMatthias Barton, Matthias R Meyer, Eric R ProssnitzPageof 13